Category: Gene Editing
Europe Gene Editing
-
Gene Therapy Market by Therapeutic Area (Cardiovascular Disorders, Dermatological Disorders, Genetic Disorders, Hematological Disorders, Metabolic Disorders, Muscle Disorders, Oncological Disorders, Ophthalmic Disorders and Other Disorders), Type of Vector (Adeno-associated Virus Vectors, Adenovirus Vectors, Herpes Simplex Virus Vectors, Lentivirus Vectors, Non-viral Vectors, Retrovirus Vectors and Other Viral Vectors), Type of Therapy (Gene Augmentation, Gene Editing, Gene Regulation, Oncolytic Immunotherapies and Other Therapies), Type of Gene Delivery Method (Ex Vivo Gene Delivery and In vivo Gene Delivery), Route of Administration (Intramuscular Route, Intratumoral Route, Intravenous Route, Subretinal Route and Other Routes of Administration), Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Rest of the World), Leading Players and Sales Forecast: Industry Trends and Global Forecasts, Till 2035
... Virus Vectors, Lentivirus Vectors, Non-viral Vectors, Retrovirus Vectors and Other Viral Vectors), Type of Therapy (Gene Augmentation, Gene Editing, Gene Regulation, Oncolytic Immunotherapies and Other Therapies), Type of Gene Delivery Method (Ex Vivo Gene Delivery ... Read More
-
Mice Model Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global mice model market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global mice ... Read More
-
Recombinant Dna Technology Market, By Product Type (Recombinant Protein Drugs, Vaccines , Genetically Modified Crops, Cell and Gene Therapy, and Gene Editing), By Application (Therapeutics, Agriculture, Research, and Others), By End User (Biotechnology and Pharmaceutical Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Recombinant DNA technology is the joining together of DNA molecules from two different ... Read More
-
CRISPR Technology Market, By Product (Enzymes, Kits & Reagents, Guide RNA, and Others), By Application (Biomedical, Agricultural, Industrial, and Others), By End User (Pharmaceutical companies and Biotechnology Companies, Academics and Government Research Institutes, and Others (CROs etc.)), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... (CROs etc.)), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 CRISPR technology is driving advances in genome editing across ... Read More
-
Europe Synthetic Biology Market Size, Share & Trends Analysis Report By Application, By End-use, By Product, By Technology (PCR Technology, NGS Technology, Genome Editing Technology, Bioprocessing Technology and Others), By Country and Growth Forecast, 20
... - 2030 The Europe Synthetic Biology Market would witness market growth of 18.5% CAGR during the forecast period (2023-2030). Synthetic biology, an interdisciplinary field combining principles from biology, engineering, and computer science, has emerged as ... Read More
-
Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032
... billion by 2032, witnessing a CAGR of 27.24% during the forecast period 2023-2032. The gene editing technologies market is anticipated to experience growth primarily due to the rising demand for personalized medicine. Furthermore, the introduction ... Read More
-
US and Europe Gene Editing Market Forecast to 2030 - Country Analysis by Technology [CRISPR, TALEN, Antisense, Zinc Finger Nucleases (ZFNs), and Others], Product and Service (Reagents and Consumables, Instruments, and Others), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, and Others)
... Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, and Others) The US & EU gene editing market is projected to ... Read More
-
Gene Editing beyond CRISPR Market, 2022-2035: Focus on Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs) and Meganucleases Edited Therapies: Distribution by Type of Payment (Upfront and Milestone Payment) and Distribution by Geography (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
... America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035 INTRODUCTION Isolation of the first site-specific restriction enzyme, Hind II, in the 1970s, became one of the breakthrough advances in biotechnology. ... Read More
-
Biohacking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... biohacking market is experiencing rapid growth driven by increasing awareness about biohacking and the prevalence of chronic diseases. Technological disruptions, particularly from the Internet of Things (IoT), have led to the development of sophisticated medical ... Read More
-
Cell Therapy Manufacturing Market, by Therapy Type (Allogeneic Cell Therapy, Autologous Cell Therapy), by Technology Type (Somatic Cell Technology, Cell Immortalization, Technology, Viral Vector Technology, Genome Editing, Technology, Cell Plasticity Technology, 3D Technology), by Source (IPSC’s (Induced pluripotent stem cell), Bone Marrow, Umbilical Cord, Adipose Tissue, Neural Stem), by Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... (IPSC’s (Induced pluripotent stem cell), Bone Marrow, Umbilical Cord, Adipose Tissue, Neural Stem), by Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and ... Read More
-
Recombinant DNA Technology Market, by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy and Gene Editing), by Application (Therapeutics, Agriculture, and Research), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Recombinant DNA (rDNA) technology is a novel technique that has led to advances in a number of ... Read More
-
Europe Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in Europe is expected to grow from US$ 1,487.30 million in 2021 to US$ 4,791.46 million by 2028; it ... Read More
Research Assistance
